A high fiber diet promotes gut bacteria that helps blood glucose control in patients with type 2 diabetes.
The American College of Physicians has developed recommendation statements to guide clinicians in selecting targets for pharmacologic treatment of type 2 diabetes.
HbA1C, diabetes status, and cognitive decline during a span of 10 years were compared using data from the English Longitudinal Study of Ageing.
The ADA's updates include a modified patient-focused care algorithm as well as improved risk management for CVD.
In this 30-year prospective cohort study, self-reported duration of lactation in women of childbearing age was associated with a lower risk of development of diabetes.
The FDA has approved the Dermapace System for treatment of chronic, full-thickness diabetic foot ulcers.
The new FDA approved short-acting insulin drug can be used to treat T1 and T2 diabetes.
With the help of a doctor and a weight loss plan, new research suggests type 2 diabetes can be reversed in less than a year.
The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Oral insulin usage does not prevent the development of type 1 diabetes in relatives of patients.
Primary care referral to Weight Watchers meetings is associated with weight loss, HbA1c reduction.
Statins are associated with an increased risk for developing type 2 diabetes, especially for high-risk individuals.
With a little creativity, children with diabetes can enjoy the festivities of Halloween.
Type 2 diabetes risk is increased in young adults through antidepressant use, specifically the duration of use and the cumulative dose.
Type 2 diabetes is greater with second-generation antipsychotics than with non-second-generation antipsychotic psychotropic medications for patients aged 6 to 25 years.
Insulin pump therapy is linked to lower risks of severe hypoglycemia and diabetic ketoacidosis and better glycemic control than insulin injection therapy.
The system uses a small sensor implanted below the skin and a mobile reader to continuously monitor blood glucose.
After the inclusion of recent negative studies, a statistically significant association between AD use and diabetes was observed.
The 12-year results show that Roux-en-Y gastric bypass offered long-term durability of weight loss and was associated with fewer obesity-related coexisting conditions compared with those who did not have the surgery.
The statement includes advances in care since the ADA's last position statement was published in 2003.
Sleep duration for 1 hour longer was associated with lower BMI, fat mass, insulin resistance, and fasting glucose but had no effect on HbA1c or cardiovascular risk.
Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.
Consumption of alcohol 3 to 4 days weekly is associated with a significantly lower risk for diabetes in men and women.
Lifestyle interventions reduce gestational weight gain across various subgroups of women and lower the odds of cesarean section without affecting offspring outcomes.
HIV-infected patients on ART had approximately 4 and 1.5 greater odds of developing diabetes mellitus and metabolic syndrome, respectively.
Degludec is noninferior to glargine regarding the incidence of major cardiovascular events among patients with type 2 diabetes.
A 36-year-old man with type 1 diabetes presents to the emergency room with hyperglycemia and possible diabetic ketoacidosis after not taking his insulin for 3 days.
Almost half of participants reported that they never received information regarding the side effects of their medication from their prescriber.
The score can predict the effectiveness of weight-loss therapy for preventing diabetes in overweight or obese individuals.
Patients exhibiting moderate-to-severe depressive symptoms had worse adherence than nondepressed patients.